{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-26-002472","form_type":"8-K","ticker":"VNRX","cik":"0000093314","company_name":"VOLITIONRX LTD","filed_at":"2026-04-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.950599+00:00","generated_at":"2026-05-15T04:46:47.229866+00:00","sec_items":["3.01","8.01","9.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"NYSE American accepts VolitionRx compliance plan; shares continue trading until Aug 2027 review","bullets":["Received non-compliance notice on Feb 6, 2026 for stockholders' equity deficiency (below $2M threshold).","Compliance plan submitted by March 8, 2026; accepted by NYSE American on April 22, 2026.","Company has until August 6, 2027 to regain compliance; subject to periodic NYSE American review.","If plan progress insufficient or compliance not met by deadline, delisting proceedings may be initiated.","No immediate impact on listing; common stock continues trading under symbol VNRX on NYSE American."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-26-002472","json":"https://secwatch.observer/filing/0001477932-26-002472.json","markdown":"https://secwatch.observer/filing/0001477932-26-002472.md","text":"https://secwatch.observer/filing/0001477932-26-002472.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/93314/000147793226002472/0001477932-26-002472-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/93314/000147793226002472/vnrx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T04:46:47.229866+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}